Virax Biolabs Group Limited (VRAX)

$2.94 +0.32 (12.21%)
Market Cap 2.09M
Revenue (ttm) 10,000.00
Net Income (ttm) -5.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -50,200.00%
Debt to Equity Ratio 0.00
Volume 502,900
Avg Vol 1,940,000
Day's Range N/A - N/A
Shares Out 797,000.00
Stochastic %K 30%
Beta 1.35
Analysts Sell
Price Target $25.00

Company Profile

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7788 7414
Address:
BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom
JaxJake
JaxJake Aug. 4 at 4:43 PM
$VRAX Dipped my toe in. Lets see if it repeats that ah pump from yesterday.
0 · Reply
Kiefer7170
Kiefer7170 Aug. 4 at 1:42 PM
$CNET $VRAX eyes on
1 · Reply
ArgusDune1971
ArgusDune1971 Aug. 4 at 12:30 PM
$VRAX
1 · Reply
Ucan2
Ucan2 Aug. 4 at 12:03 PM
$VRAX OK, I’m in- let’s do this!!
0 · Reply
diamondcrustedtips
diamondcrustedtips Aug. 4 at 11:38 AM
$VRAX “The latest government update confirms 3,802 cases and 1,707 fatalities as of Tuesday. Dr Jean Kaseya, Director-General of Africa CDC, expressed uncertainty regarding when the outbreak might peak during a visit to Bunia, near the epicentre.”
0 · Reply
Water03
Water03 Aug. 4 at 11:21 AM
$VRAX the ebola is contained - its a 2m company - with no licensed peptide - please can someone correct me - and help me understand why people think this can get to a 10 million market cap ?
0 · Reply
DannyGh8st
DannyGh8st Aug. 4 at 11:05 AM
$VRAX Here we go
0 · Reply
Aleexandder
Aleexandder Aug. 4 at 11:02 AM
$VRAX
0 · Reply
MrGreenth
MrGreenth Aug. 4 at 11:00 AM
$VRAX Any news could send this flying
0 · Reply
TwinTurboBul161
TwinTurboBul161 Aug. 4 at 10:57 AM
$VRAX is getting a lot of attention! Could be the next massive runner📈 Never chase those big moves that are up 500%+ .. Easy way to lose! Key is to buy early before the runs happen!!💎 These tiny float tickers are running 100-400% recently!! VRAX starting to get discovered and trending on Stocktwits!! Only 699k shares outstanding - keep it on watch bulls!! Might run like $DFNS $HYFM $RITR Did too
0 · Reply
Latest News on VRAX
Virax Biolabs files to sell 1.68M ordinary shares for holders

2026-07-24T20:25:13.000Z - 10 days ago

Virax Biolabs files to sell 1.68M ordinary shares for holders

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Jul 16, 2026, 7:30 AM EDT - 19 days ago

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 10, 2026, 4:05 PM EDT - 24 days ago

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Jul 9, 2026, 1:35 PM EDT - 25 days ago

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Why this biotech stock more than tripled on Thursday

Jul 9, 2026, 12:33 PM EDT - 26 days ago

Why this biotech stock more than tripled on Thursday

Why Is Penny Stock Virax Biolabs (VRAX) Up Today?

2026-07-09T13:23:51.000Z - 26 days ago

Why Is Penny Stock Virax Biolabs (VRAX) Up Today?

Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics

2026-07-09T11:35:58.000Z - 26 days ago

Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

Jul 9, 2026, 7:30 AM EDT - 26 days ago

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

Virax Biolabs Group Ltd trading halted, news pending

2026-06-25T23:50:16.000Z - 5 weeks ago

Virax Biolabs Group Ltd trading halted, news pending

Virax Biolabs approves share consolidation program

2026-06-24T13:05:25.000Z - 5 weeks ago

Virax Biolabs approves share consolidation program

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

Jun 24, 2026, 9:00 AM EDT - 5 weeks ago

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

Virax Biolabs reports pilot data for ViraxImmune in Long COVID

2026-05-26T13:04:03.000Z - 2 months ago

Virax Biolabs reports pilot data for ViraxImmune in Long COVID

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

May 26, 2026, 7:30 AM EDT - 2 months ago

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

Virax Biolabs CEO outlines strategic priorities, near-term milestones

2026-04-14T11:58:17.000Z - 4 months ago

Virax Biolabs CEO outlines strategic priorities, near-term milestones

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Apr 14, 2026, 7:34 AM EDT - 4 months ago

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Mar 31, 2026, 7:34 AM EDT - 4 months ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

2026-01-09T17:26:12.000Z - 7 months ago

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

Virax Biolabs files to sell 25.875M ordinary shares for holders

2025-12-18T21:15:19.000Z - 8 months ago

Virax Biolabs files to sell 25.875M ordinary shares for holders

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 4, 2025, 4:05 PM EST - 8 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Virax Biolabs Group Limited Announces $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 8 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

2025-12-03T13:54:57.000Z - 8 months ago

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Dec 3, 2025, 7:34 AM EST - 8 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

2025-11-03T13:36:20.000Z - 9 months ago

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Nov 3, 2025, 8:29 AM EST - 9 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

2025-08-26T11:35:28.000Z - 1 year ago

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Aug 26, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 29, 2025, 7:35 AM EDT - 1 year ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Virax Biolabs receives noncompliance notice from Nasdaq

2025-07-19T02:25:41.000Z - 1 year ago

Virax Biolabs receives noncompliance notice from Nasdaq

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025, 4:15 PM EDT - 1 year ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs initiated with a Buy at H.C. Wainwright

2025-03-31T10:15:46.000Z - 1 year ago

Virax Biolabs initiated with a Buy at H.C. Wainwright

Virax Biolabs enrolls first patients in T-cell dysfunction study

2025-03-18T11:36:57.000Z - 1 year ago

Virax Biolabs enrolls first patients in T-cell dysfunction study

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

2025-01-13T14:41:05.000Z - 1 year ago

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

COSM

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

2024-12-10T12:35:42.000Z - 1 year ago

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs announces distribution agreement with Europa Biosite

2024-10-23T11:35:15.000Z - 1 year ago

Virax Biolabs announces distribution agreement with Europa Biosite

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Cosmos Health enters exclusivity agreement with Virax Biolabs

2024-09-23T13:20:29.000Z - 2 years ago

Cosmos Health enters exclusivity agreement with Virax Biolabs

COSM

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 2 years ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 2 years ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Sep 9, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 29, 2024, 9:03 AM EDT - 2 years ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 2:18 PM EDT - 2 years ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 28, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 23, 2024, 4:09 PM EDT - 2 years ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 2 years ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 2 years ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 12, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Sep 1, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Aug 3, 2023, 7:30 AM EDT - 3 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jul 18, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

JaxJake
JaxJake Aug. 4 at 4:43 PM
$VRAX Dipped my toe in. Lets see if it repeats that ah pump from yesterday.
0 · Reply
Kiefer7170
Kiefer7170 Aug. 4 at 1:42 PM
$CNET $VRAX eyes on
1 · Reply
ArgusDune1971
ArgusDune1971 Aug. 4 at 12:30 PM
$VRAX
1 · Reply
Ucan2
Ucan2 Aug. 4 at 12:03 PM
$VRAX OK, I’m in- let’s do this!!
0 · Reply
diamondcrustedtips
diamondcrustedtips Aug. 4 at 11:38 AM
$VRAX “The latest government update confirms 3,802 cases and 1,707 fatalities as of Tuesday. Dr Jean Kaseya, Director-General of Africa CDC, expressed uncertainty regarding when the outbreak might peak during a visit to Bunia, near the epicentre.”
0 · Reply
Water03
Water03 Aug. 4 at 11:21 AM
$VRAX the ebola is contained - its a 2m company - with no licensed peptide - please can someone correct me - and help me understand why people think this can get to a 10 million market cap ?
0 · Reply
DannyGh8st
DannyGh8st Aug. 4 at 11:05 AM
$VRAX Here we go
0 · Reply
Aleexandder
Aleexandder Aug. 4 at 11:02 AM
$VRAX
0 · Reply
MrGreenth
MrGreenth Aug. 4 at 11:00 AM
$VRAX Any news could send this flying
0 · Reply
TwinTurboBul161
TwinTurboBul161 Aug. 4 at 10:57 AM
$VRAX is getting a lot of attention! Could be the next massive runner📈 Never chase those big moves that are up 500%+ .. Easy way to lose! Key is to buy early before the runs happen!!💎 These tiny float tickers are running 100-400% recently!! VRAX starting to get discovered and trending on Stocktwits!! Only 699k shares outstanding - keep it on watch bulls!! Might run like $DFNS $HYFM $RITR Did too
0 · Reply
JustBen47
JustBen47 Aug. 4 at 10:54 AM
$VRAX Great squeeze potential, float remains 700k any volume spike can send this one
0 · Reply
VincenzoPaol
VincenzoPaol Aug. 4 at 10:53 AM
$VRAX Goes over 3,1$ and this thing could move fast to the 4-5$ range
0 · Reply
DannyGh8st
DannyGh8st Aug. 4 at 10:52 AM
$VRAX bottomed out nano floater could squeeze up any time
0 · Reply
TwinTurboBul161
TwinTurboBul161 Aug. 4 at 10:50 AM
$VRAX
0 · Reply
Aleexandder
Aleexandder Aug. 4 at 10:46 AM
$VRAX Getting thinner for that 7am break-out
0 · Reply
Luciano100
Luciano100 Aug. 4 at 10:44 AM
$VRAX Still holding up well everything in the 3$ range is going to be golden!!
0 · Reply
JustBen47
JustBen47 Aug. 4 at 10:42 AM
$VRAX Let the weak hands out, this is just getting started
0 · Reply
MrGreenth
MrGreenth Aug. 4 at 10:39 AM
$VRAX Ran hard on low volume yesterday, imagine what it could do on BIG volume!!
0 · Reply
TwinTurboBul161
TwinTurboBul161 Aug. 4 at 10:34 AM
$VRAX ran +500% last month on these fantastic news.. VRAX is one I added heavier today due to increasing Ebola headlines!! VRAX has an unique peptide in this segment and a low float + healthy cash position. $RAIN $ELPW are also to watch, but I prefer VRAX. The Ebola theme is on fire once again. Lets see if $SPY $QQQ are affected by it short term..
0 · Reply
JustBen47
JustBen47 Aug. 4 at 10:31 AM
$VRAX Bullish red to green momentum
0 · Reply
Aleexandder
Aleexandder Aug. 4 at 10:29 AM
$VRAX Bids are getting stacked up
0 · Reply
VincenzoPaol
VincenzoPaol Aug. 4 at 10:27 AM
$VRAX Could be a MAASSIIVE EBOLA play and run 200-400% from this levels.
0 · Reply